Why is Vivo Bio Tech falling/rising?

As of 23-Jul, Vivo Bio Tech Ltd. is experiencing a price increase, currently at 35.47, reflecting a change of 0.35 or 1.0% upward. Today's price summary indicates that the stock has outperformed its sector by 0.4% and has shown a trend reversal after four consecutive days of decline. Despite this positive movement, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past year, the stock has generated a return of -5.89%, indicating a longer-term struggle, although it has seen a significant profit increase of 187.8%. The company's valuation appears attractive with a low enterprise value to capital employed ratio, but a decrease in promoter holding to 39.06% raises concerns about insider confidence.
In the broader market context, the stock's short-term performance is notably weaker than the benchmark, with a 1-week return of -3.30% compared to the Sensex's slight gain of +0.11%. This underperformance is consistent with the stock's negative returns over the past month and year, where it has lagged behind the benchmark indices. The company's long-term fundamentals are weak, evidenced by a -3.36% CAGR growth in net sales over the last five years and a poor EBIT to interest ratio, which suggests challenges in servicing its debt. Overall, while there are some positive indicators in the recent price movement, the stock's long-term outlook remains concerning, contributing to its mixed performance in the market.